Quest Diagnostics Officer & Director Files Form 144 for $2.43M Planned Sale
QUEST DIAGNOSTICS INC
Subscribe to track DGX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š¢ Form 144 Filing Alert: QUEST DIAGNOSTICS INC ($DGX) š¤ Insider: Davis J. E. (Officer & Director) š Filing Date: 2026-09-01 | Approx. Sale Date: 2026-09-01 š° Proposed Sale: 10,000 Common shares (~$2,427,200.00) š Trading Plan: Rule 10b5-1 adopted on 08/26/2025 š¦ Broker: Fidelity Brokerage Services LLC
Comprehensive Analysis
Executive Summary
On September 1, 2026, Davis J. E., an Officer and Director of QUEST DIAGNOSTICS INC ($DGX), filed a Form 144 notice of proposed sale for 10,000 shares of common stock with an estimated market value of $2,427,200.00 (~$242.72 per share).
Key Transaction Details
- Filer: Davis J. E. (Officer / Director)
- Shares Offered: 10,000 Common shares
- Aggregate Market Value: $2,427,200.00
- Approximate Sale Date: September 1, 2026
- Broker: Fidelity Brokerage Services LLC
- Source of Shares: Restricted stock vesting acquired between February 2022 and February 2024 as compensation.
- Rule 10b5-1 Trading Plan: The filing indicates a plan adoption date of August 26, 2025.
Prior Sales & Context
- Over the past three months, the insider sold 10,000 shares on June 1, 2026, generating gross proceeds of $1,941,400.00.
- With 110,373,360 shares outstanding, the proposed sale represents less than 0.01% of total common shares outstanding, presenting minimal dilution or liquidity pressure.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.
